Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Dr. Beatriz Barquiel Alcalá | Qualitative Research | Best Research Article Award

Hospital Universitario La Paz | Spain

Dr. Beatriz Barquiel Alcalá is a physician-scientist specializing in endocrinology and nutrition, with a clinical appointment since 2010 at Hospital Universitario La Paz in Madrid. She holds a Licentiate in Medicine and Surgery from the University of Granada (2005) and completed further training under RD 99/2011 at the Universidad Autónoma de Madrid in 2012. Over her career she has published widely on diabetes and pregnancy, gestational and pregestational diabetes, maternal weight gain, and metabolic outcomes, including contributions as corresponding author. Her work spans over 30 scientific articles (e.g. on glycemic control, gestational weight gain, twin versus singleton pregnancies, neonatal outcomes, continuous glucose monitoring) as well as book chapters on hypertensive disorders, exercise in gestational diabetes, and obesity in pregnancy. She has led or participated in multiple funded projects—among them randomized trials and studies on biomarker validation, dietary interventions in pregnancy, and predictors of glycemic control. She also undertook a research stay at Memorial Sloan Kettering (USA) in 2009–2010. Her research interests lie at the intersection of maternal–fetal medicine, diabetes, metabolic programming, and endocrinology innovations.

Profile : Scopus

Featured Publications

Aguilera-García, I., Barquiel-Alcalá, B., Vázquez-Pérez, P., Prados-Sánchez, M.C., & González-Pérez de Villar, N. (2025). Time to change guidelines? Suboptimal glycemic control measures by CGM associated with cystic fibrosis exacerbations despite adequate HbA1c. Acta Diabetológica.

Borrego Soriano, I., Barquiel-Alcalá, B., Moreno-Domínguez, O., Qasem Moreno, A.L., García-Pérez de Sevilla, E., & González-Pérez de Villar, N. (2025). Screening system for the detection of unknown or poorly controlled diabetes mellitus in a tertiary hospital: A retrospective study. Journal of Evaluation in Clinical Practice.

Quirós, C., Herrera, M.T., Amigó, J., Perea, V., Barquiel, B., et al. (2024). Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technology & Therapeutics.

Barquiel, B. (AC), Calvo, M., Moreno-Domínguez, O., Bartha, J.L., et al. (2023). The PREDG study: A randomised controlled trial testing whether an educational intervention can prevent gestational weight gain in women with obesity. Clinical Nutrition ESPEN.

García-Moreno, C., Benítez-Valderrama, P., Barquiel, B., González-Pérez de Villar, N., Hillman, N., Lora Pablos, A., & Herranz, L. (2022). Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials. Diabetic Medicine.

 

Tian Tian | Data Analysis | Best Researcher Award

Dr. Tian Tian | Data Analysis | Best Researcher Award

The Affiliated Hospital of Qingdao University | China

Dr. Tian Tian is an accomplished Associate Professor of Obstetrics and Gynecology, recognized for her expertise in gynecologic oncology, pelvic floor disorders, and inflammatory diseases affecting women’s health. Combining extensive clinical acumen with a strong foundation in translational research, she bridges the gap between patient care and innovative medical science. Her career reflects a deep commitment to improving surgical outcomes, refining treatment algorithms, and guiding evidence-based protocols in complex gynecologic conditions. She is known for mentoring residents and fellows, fostering the next generation of specialists in women’s health.

Professional Profile

SCOPUS

Education

Dr. Tian Tian earned her Doctor of Philosophy in a specialized field of obstetrics and gynecology, equipping her with advanced scientific, clinical, and analytical skills. Her education included rigorous training in translational medicine, surgical innovation, and data-driven clinical research, enabling her to tackle intricate challenges in gynecologic oncology and pelvic floor disorders. This strong academic foundation provided the tools to integrate cutting-edge technology, such as minimally invasive surgical approaches and predictive analytics, into her medical practice.

Experience

With extensive academic and clinical experience, Dr. Tian serves as an Associate Professor of Obstetrics and Gynecology, leading both patient care and research initiatives. In her role, she oversees surgical and systemic management of gynecologic cancers, incorporating advanced laparoscopic and robotic-assisted procedures. She has pioneered techniques in pelvic floor reconstruction, focusing on improving quality of life for patients suffering from prolapse and incontinence. Her experience extends to the development of clinical pathways for managing recurrent infections and inflammatory gynecologic conditions. Dr. Tian is equally committed to teaching, supervising residents and fellows, and promoting excellence in surgical skill acquisition and patient-centered care.

Research Interest

Dr. Tian’s research lies at the intersection of clinical practice and translational science. She specializes in utilizing large-scale clinical datasets to optimize oncology treatment algorithms, particularly identifying biomarkers and predictors of therapeutic response, such as those for PARP inhibitor efficacy in ovarian cancer. Her research also incorporates cost-effectiveness analyses of novel therapies, ensuring that innovative treatments are not only clinically effective but also economically viable for broader healthcare systems. She maintains a strong interest in refining surgical interventions for pelvic floor disorders and in developing evidence-based guidelines for managing chronic inflammatory conditions in gynecology.

Awards

Dr. Tian’s contributions to women’s health have been recognized through academic honors, professional awards, and invitations to present at leading medical conferences. Her innovative approaches in gynecologic oncology and pelvic floor reconstruction have earned her accolades from both clinical and research communities. Her role as a mentor has also been acknowledged through teaching awards, reflecting her dedication to education and leadership in her field.

Publications

Comparative effectiveness and safety of treatment regimens for recurrent advanced ovarian cancer: a systematic review and network meta-analysis
  • Authors: Xingfa Huo, Tian Tian, Xiaochun Zhang, Na Zhou

  • Journal: World Journal of Surgical Oncology

  • Year: 2025

Clinical characteristics and prognosis of rhabdomyosarcoma in the female reproductive system: a population-based analysis using SEER data
  • Authors: Xinyan Gao, Yan Kong, Ying Ning, Zhumei Cui, Ke Lei, Tian Tian

  • Journal: International Journal of Gynecological Cancer

  • Year: 2025

Conclusion

Dr. Tian Tian’s career embodies a rare balance of surgical excellence, scientific rigor, and compassionate care. Her impact extends beyond the operating room and research laboratory, shaping the future of obstetrics and gynecology through innovation, mentorship, and dedication to patient outcomes. By integrating data science, precision medicine, and advanced surgical techniques, she continues to push the boundaries of women’s healthcare. Her work not only transforms individual patient journeys but also influences clinical guidelines and healthcare policy, leaving a lasting legacy in the field.